Insider Shareholders with Direct Ownership of Century Therapeutics, Inc. (IPSC)
This section provides a comprehensive overview of the insiders with direct ownership of Century Therapeutics, Inc. (IPSC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Century Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Aktiengesellschaft Bayer
> 10% Shareholder |
12,675,838 | 0 | 12,675,838 $32.3 Million | 1 |
Jun 22, 2021
Added 5.59%
|
|
Versant Venture Capital Vi, L.P.
> 10% Shareholder |
9,936,011 | 1,464,800 | 11,452,014 $29.2 Million | 4 |
Aug 09, 2022
Reduced 3.09%
|
|
Fujifilm Cellular Dynamics, Inc.
> 10% Shareholder |
3,974,404 | 0 | 6,955,207 $17.7 Million | 1 |
Jun 22, 2021
Added 36.36%
|
|
Brent Pfeiffenberger
President and CEO |
1,470,704 | 0 | 1,470,704 $3.75 Million | 2 |
Mar 07, 2024
Added 1.17%
|
|
Douglas Carr
SVP Finance & Operations |
166,853 | 18,068 | 334,330 $852,541 | 8 |
Jun 07, 2024
Added 4.84%
|
|
Gregory Russotti
Officer |
24,000 | 25,000 | 277,319 $707,163 | 6 |
Jun 20, 2024
Reduced 1.77%
|
|
Luis Borges
Chief Scientific Officer |
401,446 | 144,911 | 256,535 $654,164 | 8 |
Apr 03, 2023
Added 2.82%
|
|
Michael Craig Diem
Chief Financial Officer |
194,808 | 20,763 | 253,533 $646,509 | 3 |
Nov 01, 2023
Reduced 7.57%
|
|
Adrienne Farid
Chief Operations Officer |
121,750 | 58,732 | 137,236 $349,951 | 10 |
May 03, 2024
Reduced 0.66%
|
|
Hyam Levitsky
President of R&D |
24,000 | 0 | 24,000 $61,199 | 1 |
Mar 07, 2024
Added 50.0%
|